Sort
30,917 grants matching “tumor microenvironment”
Rewiring T cell exhaustion with immune checkpoint blockade therapy
$674,996Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · CA
Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas
$674,985Anirban Maitra · University Of Tx Md Anderson Can Ctr · U01 · FY2020 · CA
The Role of TIMPs in Cell Growth and Differentiation: Tumor Angiogenesis
$674,959William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
Translational Application of Magnetic Hyperthermia Therapy with Adjuvant Therapies for Glioblastoma
$674,894Constantinos George Hadjipanayis · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA
Understanding and Improving Platinum Anticancer Drugs
$674,719Stephen J Lippard · Massachusetts Institute Of Technology · R01 · FY2014 · CA
Understanding and Improving Platinum Anticancer Drugs
$674,719Stephen J Lippard · Massachusetts Institute Of Technology · R01 · FY2016 · CA
Understanding and Improving Platinum Anticancer Drugs
$674,719Omer Yilmaz · Massachusetts Institute Of Technology · R01 · FY2017 · CA
Understanding and Improving Platinum Anticancer Drugs
$674,719Omer Yilmaz · Massachusetts Institute Of Technology · R01 · FY2018 · CA
Understanding and Improving Platinum Anticancer Drugs
$674,719Stephen J Lippard · Massachusetts Institute Of Technology · R01 · FY2015 · CA
Myeloma Defining Genomic Events to Differentiate Benign and Malignant Myeloma Precursor Conditions
$674,440Francesco Maura · University Of Miami School Of Medicine · R37 · FY2025 · CA
Protein kinase C and lung carcinogenesis
$674,373Marcelo Gabriel Kazanietz · University Of Pennsylvania · R01 · FY2023 · CA
Contemporary Approaches to Cancer Cell Signaling and Communication
$674,370Jing Yang · University Of California, San Diego · T32 · FY2025 · CA
The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis
$674,309William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
A Phase 1 Study of Patient-Derived Multi-Tumor Associated Antigen Specific T Cells (MT-601) Administered to Patients with Metastatic Pancreatic Cancer following frontline FOLFIRINOX
$674,275Juan Fernando Vera · Marker Therapeutics, Inc. · R44 · FY2024 · CA
A Phase 1 Study of Patient-Derived Multi-Tumor Associated Antigen Specific T Cells (MT-601) Administered to Patients with Metastatic Pancreatic Cancer following frontline FOLFIRINOX
$674,275Juan Fernando Vera · Marker Therapeutics, Inc. · R44 · FY2025 · CA
Enhancing cell therapy for brain tumors
$674,256Catherine Mary Bollard · Children'S Research Institute · U01 · FY2018 · CA
Advancing On-Slide and Optical Biopsy Tools to Detect High-Risk Oral Premalignancy
$674,252Yu Leo Lei · University Of Tx Md Anderson Can Ctr · U01 · FY2025 · DE
Click Chemistry-Mediated Surface Protein Assay for Quantifying Subpopulations of Hepatocellular Carcinoma-associated Extracellular Vesicles
$674,097Yazhen Zhu · University Of California Los Angeles · R01 · FY2023 · CA
Planning and Evaluation Core
$673,914Jefferey L Burgess · University Of Arizona · U54 · FY2023 · CA
Biological mechanisms involved with PDT in the treatment of MPM
$673,905Eli J Glatstein · University Of Pennsylvania · P01 · FY2016 · CA
Combining CDK7 and MUC1-C inhibition to target different subtypes of small cell lung cancer
$673,898Kwok Kin Wong · New York University School Of Medicine · R01 · FY2025 · CA
Magnetic Resonance Fingerprinting of Tumor Vascular Perfusion and Acidosis
$673,812Christopher A Flask · Case Western Reserve University · R01 · FY2023 · CA
Neoadjuvant Immunotherapy Platform Study Reveals Mechanisms of Response in Hepatocellular Carcinoma (HCC)
$673,789Mark Yarchoan · Johns Hopkins University · R01 · FY2025 · CA
Targeting Ã-TrCP regulators to improve CRC response to chemotherapy
$673,747Vladimir S. Spiegelman · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2025 · CA
Cancer Center Administration
$673,711Eric R. Fearon · University Of Michigan At Ann Arbor · P30 · FY2024 · CA